l

Aleukemic variant of mast cell leukemia

Aleukemic variant of mast cell leukemia
#00012648
Author: Sacha Zeerleder and Marinus van Oers
Category: Myeloid Neoplasms and acute leukemia (WHO 2016) > Acute Myeloid Leukemia > AML not otherwise specified
Published Date: 07/18/2012

A 45-year-old woman was admitted with fatigue, icterus, thrombocytopenia (77 × 109/L), normocytic anemia (9.8 g/dL), and a normal white blood cell count (8.5 × 109/L). The peripheral blood smear showed metamyelocytes, myelocytes, monocytes, erythroblasts, and atypical cells with bilobulated nuclei resembling basophil granulocytes (left panel of figure). In the bone marrow there was a nearly complete infiltration with atypical, partly degranulated mast cells expressing surface markers (CD2, CD25, and CD117; right panel of figure). These cells were also positive for c-KIT mutation (D816V). Tryptase levels in serum were elevated (719 µg/L, normal value: 0-11.4 µg/L) in the absence of symptoms arising from mediator release. A diagnosis of aleukemic variant of mast cell leukemia was made because < 10% mast cells could be detected in peripheral blood. She had no skin lesions. Four weeks after starting treatment with high-dose chemotherapy, the patient died with Klebsiella pneumonia sepsis an